GETI.B

212.1

-0.52%↓

CAMX

591.5

+0.94%↑

BIOAB

313.8

-1.01%↓

EKTA.B

56.45

+0.18%↑

AMBEA

139.4

+0.36%↑

GETI.B

212.1

-0.52%↓

CAMX

591.5

+0.94%↑

BIOAB

313.8

-1.01%↓

EKTA.B

56.45

+0.18%↑

AMBEA

139.4

+0.36%↑

GETI.B

212.1

-0.52%↓

CAMX

591.5

+0.94%↑

BIOAB

313.8

-1.01%↓

EKTA.B

56.45

+0.18%↑

AMBEA

139.4

+0.36%↑

GETI.B

212.1

-0.52%↓

CAMX

591.5

+0.94%↑

BIOAB

313.8

-1.01%↓

EKTA.B

56.45

+0.18%↑

AMBEA

139.4

+0.36%↑

GETI.B

212.1

-0.52%↓

CAMX

591.5

+0.94%↑

BIOAB

313.8

-1.01%↓

EKTA.B

56.45

+0.18%↑

AMBEA

139.4

+0.36%↑

Search

Vitrolife AB

Chiusa

128.1 -4.12

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

127.2

Massimo

133.5

Metriche Chiave

By Trading Economics

Entrata

-30M

102M

Vendite

-36M

835M

P/E

Media del settore

41.539

76.798

EPS

0.753

Rendimento da dividendi

0.79

Margine di Profitto

12.216

Dipendenti

1,100

EBITDA

118M

255M

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

0.79%

2.37%

Utili prossimi

3 feb 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-1.5B

18B

Apertura precedente

132.22

Chiusura precedente

128.1

Vitrolife AB Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

18 dic 2025, 23:54 UTC

Azioni calde

Stocks to Watch: Nike, Cassava Sciences, KB Home

18 dic 2025, 23:51 UTC

Utili

Nike Sales Tick Up in 2Q; China Weakness Persists -- Update

18 dic 2025, 23:39 UTC

I principali Market Mover

Cassava Sciences Shares Fall After FDA Places Hold on Epilepsy Drug Trial

18 dic 2025, 22:57 UTC

Acquisizioni, Fusioni, Takeovers

TikTok Signs Agreement for Sale of U.S. Unit, Axios Reports, Citing a Memo

18 dic 2025, 21:40 UTC

Utili

Nike Sales Tick Up, But China Weakness Persists

18 dic 2025, 23:45 UTC

Discorsi di Mercato

Gold Steady, Supported by Fed Rate-Cut Prospects -- Market Talk

18 dic 2025, 23:37 UTC

Discorsi di Mercato
Utili

Nike 2Q Results Fail to Convince Investors of Recovery -- Market Talk

18 dic 2025, 23:36 UTC

Discorsi di Mercato

Nikkei May Rise, Tracking Wall Street's Rally -- Market Talk

18 dic 2025, 23:03 UTC

Acquisizioni, Fusioni, Takeovers

Mitsubishi Materials: Impact on Consolidated Results for FY Ending March 2026 Likely to be Immaterial

18 dic 2025, 23:02 UTC

Acquisizioni, Fusioni, Takeovers

Mitsubishi Materials: To Acquire 4,448 Common Shares, 13,771 Preferred Shares of Co.

18 dic 2025, 23:00 UTC

Acquisizioni, Fusioni, Takeovers

Mitsubishi Materials: Investment to Strengthen Recovery Network in U.S.

18 dic 2025, 22:59 UTC

Acquisizioni, Fusioni, Takeovers

Mitsubishi Materials: Investment to Contribute to Expanding Collection Volume of Secondary Raw Material

18 dic 2025, 22:58 UTC

Acquisizioni, Fusioni, Takeovers

SpaceX Could Go Public by Merging With EchoStar. It Isn't a Crazy Idea. -- Barrons.com

18 dic 2025, 22:57 UTC

Acquisizioni, Fusioni, Takeovers

Mitsubishi Materials: Elemental USA E-Waste Operates E-Waste Recycling Business in U.S.

18 dic 2025, 22:56 UTC

Acquisizioni, Fusioni, Takeovers

Mitsubishi Materials: To Acquire Portion of Shares of Elemental USA E-Waste & ITAD

18 dic 2025, 22:55 UTC

Utili

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18 dic 2025, 21:59 UTC

Utili

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18 dic 2025, 21:50 UTC

Discorsi di Mercato
Utili

Tech, Media & Telecom Roundup: Market Talk

18 dic 2025, 21:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

18 dic 2025, 21:35 UTC

Utili

FedEx's Earnings Were Strong. Cost Cuts and Shipment Volume Helped. -- Barrons.com

18 dic 2025, 21:31 UTC

Utili

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18 dic 2025, 21:15 UTC

Utili

Nike 2Q Europe, Middle East & Africa Rev $3.39B >NKE

18 dic 2025, 21:15 UTC

Utili

Nike 2Q Greater China Rev Down 17% >NKE

18 dic 2025, 21:15 UTC

Utili

Nike 2Q EPS 53c >NKE

18 dic 2025, 21:15 UTC

Utili

Nike 2Q Apparel Rev $3.91B >NKE

18 dic 2025, 21:15 UTC

Utili

Nike 2Q Equipment Rev $550M >NKE

18 dic 2025, 21:15 UTC

Utili

Nike 2Q N Amer Rev $5.63B >NKE

18 dic 2025, 21:15 UTC

Utili

Nike 2Q Footwear Rev $7.66B >NKE

18 dic 2025, 21:15 UTC

Utili

Nike 2Q Asia Pacific & Latin America Rev Down 4% >NKE

18 dic 2025, 21:15 UTC

Utili

Nike 2Q Greater China Rev $1.42B >NKE

Confronto tra pari

Modifica del prezzo

Vitrolife AB Previsione

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems. The company operates in Europe, the Middle East, India and Africa; Asia; Japan and Pacific; Americas; and Asia. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.
help-icon Live chat